Publication | Closed Access

Establishment of interleukin 2 dependent cytotoxic T lymphocyte cell line specific for autologous brain tumor and its intracranial administration for therapy of the tumor

Neuro-oncologyIntracranial AdministrationCancer ImmunosurveillanceInterleukin 2MedicineImmunologyImmunoeditingAutologous Brain TumorAutoimmunityBrain-immune InteractionCell TransplantationRadiation OncologyImmunotherapyGliomaNeuroimmunology